Prognostic four-gene signature for overall survival in patients with hepatocellular carcinoma Tatsuo KandaOsamu YokosukaMitsuhiko Moriyama Editorial 16 August 2019 Pages: 519 - 520
Clinical immunology and immunotherapy for hepatocellular carcinoma: current progress and challenges Lifeng WangFu-Sheng Wang Review Article 27 July 2019 Pages: 521 - 533
Reversal of NASH fibrosis with pharmacotherapy Joseph J. AlukalPaul J. Thuluvath Review Article 30 July 2019 Pages: 534 - 545
Radiomics in hepatocellular carcinoma: a quantitative review Taiga WakabayashiFarid OuhmichBenoit Gallix Review Article 31 August 2019 Pages: 546 - 559
The prognostic role of liver stiffness in patients with chronic liver disease: a systematic review and dose–response meta-analysis Yue ShenSheng-Di WuWei Jiang Original Article 04 July 2019 Pages: 560 - 572
Sequential combination therapy with interferon, interleukin-2 and therapeutic vaccine in entecavir-suppressed chronic hepatitis B patients: the Endeavor study Di WuPeng WangQin Ning Original Article 06 June 2019 Pages: 573 - 586
Direct-acting antivirals in East Asian hepatitis C patients: real-world experience from the REAL-C Consortium Chung-Feng HuangEtsuko IioFor the REAL-C Investigators Original Article 28 August 2019 Pages: 587 - 598
The change in the nationwide seroprevalence of hepatitis C virus and the status of linkage to care in South Korea from 2009 to 2015 Eun Sun JangMoran KiThe Korean hepatitis epidemiology study group Original Article 20 August 2019 Pages: 599 - 608
Association between neutrophil–lymphocyte ratio, socioeconomic status, and ethnic minority with treatment outcome in hepatocellular carcinoma Yifei ZhangN. Patrik BrodinRafi Kabarriti Original Article 01 August 2019 Pages: 609 - 617
Identification and validation of a prognostic four-genes signature for hepatocellular carcinoma: integrated ceRNA network analysis Yongcong YanYingjuan LuZhiyu Xiao Original Article Open access 18 July 2019 Pages: 618 - 630
An imbalance between stellate cells and γδT cells contributes to hepatocellular carcinoma aggressiveness and recurrence Bao-Yong ZhouJun-Hua GongRui Liao Original Article 24 July 2019 Pages: 631 - 640
Asparaginase-induced hepatotoxicity: rapid development of cholestasis and hepatic steatosis Natasha KamalChristopher Kohfor the Drug-Induced Liver Injury Network Original Article 07 August 2019 Pages: 641 - 648